First patient dosed in CDD Phase 2 trial of new pancreatic drug ginisortamab
Beyond Borders: going global with clinical trials
CDD and the Norwegian Cancer Society partner to bring more novel treatments into the clinic
First patient dosed in CDD Phase 1 trial of Aleta Biotherapeutics' CAR T cell engager
Cancer Research UK and Stitch strengthen their partnership, collaborating on two new studies
Director of our Formulation Unit awarded OBE
Cancer Research UK appoints new director to lead its Centre for Drug Development
Patients with rare cancers given hope by UK-led ‘drug-match’ trial
New class of antibody drug shows promise for cancer patients
Topline Phase 1 study results with VAC2 for the treatment of advanced non-small cell lung cancer
Cancer Research UK joins European precision cancer medicine trial consortium
Study Details | Phase I Study of MOv18 IgE
Novartis joins Cancer Research UK trial for rare cancers
App for patients on a clinical trial piloted by Cancer Research UK
Precision medicine trial opens for rare adult and paediatric cancers
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
Study Details | A Phase I Trial of AZD3965 in Patients With Advanced Cancer
World Cancer Day: Celebrating Life-Saving Research
Tailored Patient Involvement in Clinical Trials
Cancer Research UK dose first patient in phase I/IIa trial of lung cancer immunotherapy vaccine
Cancer researchers across the UK join forces to find drugs for rare cancers
Cancer Research UK announces first patient dosed in trial for hard-to-treat cancers
Funding bodies should foster partnerships between industry and academia
Teon Therapeutics Announces Approval for Collaboration with Cancer Research UK
First-in-human trial for new lung cancer immunotherapy
A Medidata and Cancer Research UK Podcast | Patient Centricity Within Clinical Trials